Pfizer COVID-19 Vaccine Fully Approved for Children 5–11: FDA Update

Current Status (as of February 2023)

The FDA granted full approval for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) in children ages 5–11 on January 31, 2023. This follows the October 2021 Emergency Use Authorization (EUA) for this age group.

Key Evidence for Approval

  • Trial size: ~4,500 children (3,000 vaccine, 1,500 placebo)
  • Efficacy: 90.7% against symptomatic COVID-19 (pre-Omicron)
  • Safety: No serious vaccine-related adverse events. Common reactions: injection-site pain, fatigue, headache, chills—mostly mild/moderate, resolving in 1–2 days.
  • Dose: 10 µg (one-third adult dose), two doses 3 weeks apart.

CDC Recommendation

The CDC recommends COVID-19 vaccination for everyone ages 6 months and older, including the updated (bivalent) booster when eligible. Vaccination reduces severe disease, hospitalization, MIS-C, and long COVID risk in children.

Historical Context

Previous update (January 2023): The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) and CDC's ACIP reviewed data for under-5 authorization. The 5–11 full approval was based on longer follow-up and manufacturing data beyond EUA requirements.

What Full Approval Means

  • Meets FDA's rigorous standards for safety, effectiveness, and manufacturing quality.
  • Allows direct marketing to consumers.
  • May increase provider and parent confidence.
  • Does not change clinical recommendations—EUA and approved use are clinically equivalent.

Where to Get Vaccinated

Pediatricians, family doctors, pharmacies, health departments, school clinics. Vaccines.gov lists locations. Free regardless of insurance or immigration status.

Guidance for Parents

  • Discuss questions with your child's clinician.
  • Review CDC's COVID-19 Vaccination for Children resources.
  • Report any adverse events to VAERS.
  • Stay current with boosters per CDC schedule.

Full approval reinforces the robust safety and efficacy data supporting COVID-19 vaccination for children 5–11.

Pediatrics - Related Articles